RARaafat Abdel-Malek

Raafat Abdel-Malek

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Raafat Abdel-Malek has a total of 76 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Safety issues with the ALK inhibitors in the treatment of NSCLC: A systematic review

    by Loay Kassem, Kyrillus S. Shohdy, Shaimaa Lasheen, Omar Abdel-Rahman, Ahmad Ali, Raafat R. Abdel-Malek


  • Open Access

    Availability of informal caregivers for palliative care patients with cancer: Is there a difference between higher- and lower-income settings

    by Kyrillus S Shohdy, Raafat Abdel-Malek, DinaE Farag, Sarah Cox

    Objective: Family caregivers are the default caring personnel for terminal cancer patients. The characteristics, demographics, distribution, psychological burden, and socioeconomic standards differ between high- and low-income countries. We aimed to assess those factors and their direct reflection on both the patient and the caregiver. Patients and Methods: This is a comparative cross-sectional study for terminal cancer patients in the palliative care unit between the United Kingdom (UK) as a high-income community and Egypt as a low-income community. We assessed the different characteristics, demographics, living place, the degree of relevance, and the availability of caregivers. Results: We have recruited 216 patients from the UK and 117 patients from Egypt. Informal caregivers were available in 74.5% and 92.3% for these patients with a mean age of 71.5 (standard deviation [SD] 16) years and 50.9 (SD 15.18) years, respectively. There has been a statistically significant difference between the two countries' caregivers in being married, family, and living in the same household (P < 0.0001). Conclusion: Low-income countries are more common to have an informal caregiver who is a family member of different degree of relevance. Caregivers in low-income settings tend to be younger, of the female gender, married, and living in the same household than in high-income ones.


  • Safety of Vinflunine in Patients with Advanced Urothelial Carcinoma Refractory to Platinum-based Chemotherapy: A Prospective Pilot Study

    by Raafat Abdel-Malek, Kyrillus S. Shohdy, Noha Abbas, Mohamed Ismail, Emad Hamada, Yasser Abdel-Kader

    Background: Several single chemotherapeutic agents have been evaluated as the second-line treatment of advanced urothelial carcinoma. Despite encouraging efficacy outcomes, toxicity has often led to dose modifications or discontinuation. We aimed to assess the safety of vinflunine in a particular population of advanced transitional cell carcinoma of urothelium (TCCU), that were exposed to the previous toxicity of chemotherapy. Methods: This is an open-label, prospective, single-center pilot study to evaluate the response rate and safety profile of vinflunine in patients with advanced TCCU. It was planned to enroll 25 evaluable patients. Eligible patients are those with progressive disease after first-line platinum-based regimen for advanced or metastatic disease. Results: The study was prematurely closed due to two sudden deaths that were judged by the review board as treatment-related. Only ten patients were evaluated and received at least one cycle of vinflunine. All but one were male and seven underwent radical surgery. Eight had a distant metastasis (mainly lung and/or liver). Disease control rate was 40%, four patients had a partial response with median duration of response of 3.5 months. The median overall survival was 3.2 months (95% CI: 1.67-4.73). There were three serious adverse events namely two sudden deaths and one grade 4 thrombocytopenia. Nine grade 3/4 adverse events occurred. The most common all-grade adverse events were fatigue (50%), constipation (40%) and vomiting (40%). Moreover, grade 3 fatigue occurred in 30% of patients. Only one patient, who achieved PR for 5 months, was fit to receive further cytotoxic chemotherapy. Conclusion: The activity of vinflunine in advanced urothelial carcinoma came at the expense of its safety. The use of vinflunine has to be limited to the selected group of patients. However, this is a single institute experience in a limited number of patients.

  • Rationale for co-targeting CDK4/6 and FGFR pathways in urothelial carcinoma

    by Kyrillus S. Shohdy, Panagiotis J. Vlachostergios, Raafat R. Abdel-Malek, Bishoy M. Faltas

    (2018). Rationale for co-targeting CDK4/6 and FGFR pathways in urothelial carcinoma. Expert Opinion on Therapeutic Targets. Ahead of Print.


  • Transabdominal ultrasonographic features in the diagnosis of gastrointestinal lymphoma

    by Maha Hasaballah, Raafat Abdel-Malek, Zeinab Zakaria, Mohamad Saeed Marie, Mohammed Sherif Naguib

    Background: Gastrointestinal (GI) lymphoma is a challenging disease. We aimed to study and characterize the different endoscopic and transabdominal ultrasonography (TUS) features of gut lymphoma and to assess whether TUS has a complementary role to endoscopy in the diagnosis of GI lymphoma. Methods: This study was conducted on 21 patients with GI lymphoma, attending the GI endoscopy and liver unit, Endemic Medicine Department and Oncology Department in Kasr El Aini Hospital, Cairo University. Patients were subjected to GI endoscopy (upper endoscopy & colonoscopy) and transabdominal ultrasonography. The diagnosis was finally based on histopathology of core biopsies (obtained either endoscopically or by ultrasonography) and immuno-histochemistry. Results: In all 21 patients with GI lymphoma included in this study, TUS could accurately determine the site of disease affection compared to endoscopy which is considered the gold standard for site localization. The main TUS pathologic features detected were increased wall thickness of the affected bowel segment with a mean value of (15.6±5.9 mm) and loss of layering pattern in 16 patients (76%). While the most common endoscopic features were ulcers and mass lesions accounting for 38% of the patients for each. Diffuse large B-cell lymphoma was found in 19 patients (90%). Because of endoscopic biopsies were conclusive in 14 patients (67%), TUS guided biopsy was resorted to in 7 patients and was diagnostic in all of them. Conclusions: Transabdominal ultrasonography is a useful tool in the diagnosis of GI lymphoma that is complementary to conventional diagnostic endoscopic procedures.


  • Validity of a new immunochromatographic test in detection of Toxoplasma gondii in cancer patients

    by Rita Wassef, Raafat Abdel-Malek

    Screening of toxoplasmosis in cancer patients is mandatory especially before starting treatment to guard against life-threatening disseminated disease. Diagnosis of toxoplasmosis rely mainly on serology. The most widely used method for detection of anti-Toxoplasma gondii (T. gondii) antibodies is the enzyme linked immunosorbent assay (ELISA), being available and reliable. Immunochromatographic tests (ICT) attracted a lot of attention recently being one of the high quality, rapid and easy to perform tests. Available data comparing the performance of ICT versus ELISA techniques have yielded inconsistent results and none compared their performance among the immunocompromised cancer patients. Therefore, we designed this study to compare the performance of a new ICT (the OnSite Toxo IgG/IgM Combo Rapid test) and ELISA techniques for the detection of anti-T. gondii antibody as a tool for screening for toxoplasmosis among cancer patients in Cairo-Egypt. Among 180 cancer patients, a total of 110 patients (61.1%) were positive for anti-T. gondii antibodies by one or both methods. Agreement between both methods was found in 78.8% of the samples. By using ELISA technique as a gold standard test for the detection of anti-T. gondii antibodies, our results showed 87.5% specificity and 74% sensitivity of ICT technique. Moreover, our results proved that ICT is more sensitive in detecting lower level of antibodies than ELISA, that makes it preferable as a screening test for the immunocompromised patients.


  • Open Access

    Toxoplasmosis an Overlooked Disease: Seroprevalence in Cancer Patients

    by Raafat Abdel-Malek, Rita Wassef, Enas Rizk, Hoda Sabry, Nevine Tadros, Abdallah Boghdady


  • Isolated Extramedullary Relapse in a Case of Acute Myeloid Leukemia Following Allogeneic Stem Cell Transplantation

    by Raafat Abdel-Malek, Rehab Sayed, Shady E. Anis

    Background: Acute myeloid leukemia (AML) is the commonest acute leukemia in adults. Allogeneic stem celltransplantation (ASCT) is a curative option for a subset of these patients.Case Presentation: We report the case of a 36 years old female patient who presented in April 2014 with pancytopenia.Investigations revealed that she had AML (M6). She achieved complete remission with induction chemotherapy which wasfollowed by four cycles of consolidation chemotherapy until a human leukocyte antigen-matched donor was available. Sheunderwent ASCT in January 2015. After 14 months, in March 2016, she presented with left breast and rightparapharyngeal masses. Histopathological examination of the excised mass showed infiltration with myeloid cells and thebone marrow was normocellular without leukemic infiltration. She received radiotherapy to the affected breast and thecervical region followed by chemotherapy with good response.Conclusion: AML relapse following ASCT may be in the form of isolated Extramedullary disease. Further research isneeded to optimize the management of these cases.

  • Predicting Brain Metastasis in Breast Cancer Patients: Stage Versus Biology

    by Hamdy A. Azim, Raafat Abdel-Malek, Loay Kassem


  • Open Access

    The role of dynamic contrast enhanced MR imaging in the assessment of inconclusive ovarian masses

    by Wessam Abdelrahman Elzayat, Mona El-Kalioubie, Manar Magdy Abdel-Naby, Raafat Ragaie Abdel-Malek